{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:28:31Z","timestamp":1790033311249,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ARGE Ankersmit"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>In recent years, the use of biological prosthetic valves has increased in patients under 65\u2009years of age. This study evaluated overall survival, major adverse cardiac events and reoperation risk following surgical aortic valve replacement using either mechanical or biological prostheses in patients aged 50 to 65\u2009years, aiming to provide data to support optimal valve selection in this group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A registry-based cohort study was conducted using nationwide Austrian health insurance data from 1 January 2010 to 31 December 2020. Patients undergoing isolated surgical aortic valve replacement were classified based on valve type into mechanical or biological groups. The primary outcome was all-cause mortality. Secondary outcomes included major adverse cardiac events, reoperation, stroke, bleeding and survival after reoperation. Outcomes were assessed using Cox or competing risk regression models. Propensity score matching was used to reduce baseline differences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In the study cohort, 1018 patients were categorized to the mechanical and 2743 to the biological group. Patients who received mechanical valves had a significantly lower risk of death compared to those with biological valves (hazard ratio 1.352; P\u2009=\u20090.003). The biological group also had higher risks of major adverse cardiac events (hazard ratio 1.182; P\u2009=\u20090.03) and reoperation (hazard ratio 2.338; P\u2009=\u20090.002). Stroke and bleeding risks were similar between groups. All findings remained significant after propensity score matching.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Among patients aged 50 to 65\u2009years undergoing surgical aortic valve replacement, mechanical valves were associated with improved long-term survival, fewer major adverse events, and a lower need for repeat surgery. These findings suggest a need to re-evaluate the increasing use of biological valves in this age group.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezaf200","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:08:16Z","timestamp":1750997296000},"source":"Crossref","is-referenced-by-count":6,"title":["The choice of surgical aortic valve replacement type and mid-term outcomes in 50 to 65-year-olds: results of the AUTHEARTVISIT study"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7464-3407","authenticated-orcid":false,"given":"Alissa","family":"Florian","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Auer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I with Cardiology and Intensive Care, St Josef Hospital Braunau , Braunau am Inn,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Reichardt","sequence":"additional","affiliation":[{"name":"Austrian Social Health Insurance Fund , Eisenstadt,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Krotka","sequence":"additional","affiliation":[{"name":"Center for Medical Data Science, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wagenlechner","sequence":"additional","affiliation":[{"name":"Center for Medical Data Science, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Wendt","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St Georg Hospital , Leipzig,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mildner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mascherbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, University Hospital St Poelten , St Poelten,","place":["Austria"]},{"name":"Karl Landsteiner University of Health Sciences , Krems an der Donau, Vienna","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik Jan","family":"Ankersmit","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Medical University of Vienna , Vienna,","place":["Austria"]},{"name":"Laboratory for Cardiac and Thoracic Diagnosis, Regeneration and Applied Immunology ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zimpfer","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Graf","sequence":"additional","affiliation":[{"name":"Center for Medical Data Science, Medical University of Vienna , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"2025072618313518600_ezaf200-B1","first-page":"32","article-title":"Valvular heart disease epidemiology","volume":"10","author":"Aluru","year":"2022","journal-title":"Med Sci"},{"key":"2025072618313518600_ezaf200-B2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"2025072618313518600_ezaf200-B3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.hrtlng.2024.09.016","article-title":"Long-term outcomes following aortic valve replacement in bioprosthetic vs mechanical valves","volume":"69","author":"Watkins","year":"2025","journal-title":"Heart Lung"},{"key":"2025072618313518600_ezaf200-B4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2025072618313518600_ezaf200-B5","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2025072618313518600_ezaf200-B6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.2014.12679","article-title":"Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years","volume":"312","author":"Chiang","year":"2014","journal-title":"JAMA"},{"key":"2025072618313518600_ezaf200-B7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jtcvs.2020.11.181","article-title":"Similar long-term survival after isolated bioprosthetic versus mechanical aortic valve replacement: a propensity-matched analysis","volume":"164","author":"Attia","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtcvs.2017.08.121","article-title":"Bioprosthetic aortic valve replacement: revisiting prosthesis choice in patients younger than 50 years old","volume":"155","author":"Schnittman","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med"},{"key":"2025072618313518600_ezaf200-B10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jtcvs.2011.04.048","article-title":"Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use\u2014an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database","volume":"142","author":"Dunning","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B11","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/eurheartj\/ehv580","article-title":"Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50\u201369 years","volume":"37","author":"Glaser","year":"2016","journal-title":"Eur Heart J"},{"key":"2025072618313518600_ezaf200-B12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jtcvs.2012.01.024","article-title":"Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age","volume":"144","author":"Weber","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B13","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad308","article-title":"Revisiting aortic valve prosthesis choice in patients younger than 50 years: 10 years results of the AUTHEARTVISIT study","volume":"65","author":"Traxler","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025072618313518600_ezaf200-B14","doi-asserted-by":"crossref","first-page":"e13736","DOI":"10.1111\/eci.13736","article-title":"Mechanical aortic valve prostheses offer a survival benefit in 50\u201365 year olds: AUTHEARTVISIT study","volume":"52","author":"Traxler","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2025072618313518600_ezaf200-B15","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezae214","article-title":"Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study","volume":"66","author":"Auer","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025072618313518600_ezaf200-B16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","article-title":"Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial","volume":"36","author":"Hammermeister","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025072618313518600_ezaf200-B17","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.jacc.2009.07.032","article-title":"Aortic valve replacement","volume":"54","author":"Stassano","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025072618313518600_ezaf200-B18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jtcvs.2018.10.146","article-title":"Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis","volume":"158","author":"Diaz","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B19","first-page":"90","article-title":"Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis","volume":"10","author":"Jiang","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"2025072618313518600_ezaf200-B20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0037-1602825","article-title":"Survival and long-term outcomes of aortic valve replacement in patients aged 55 to 65 years","volume":"66","author":"Alex","year":"2018","journal-title":"Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B21","doi-asserted-by":"crossref","first-page":"ezac286","DOI":"10.1093\/ejcts\/ezac286","article-title":"Surgical aortic valve replacement in patients aged 50\u201369 years\u2014insights from the German Aortic Valve Registry (GARY)","volume":"62","author":"Vogt","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025072618313518600_ezaf200-B22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2024.07.006","article-title":"Long-term outcomes of mechanical versus bioprosthetic aortic valve replacement in patients aged under 50 years: meta-analysis of reconstructed time-to-event data","volume":"227","author":"Warraich","year":"2024","journal-title":"Am J Cardiol"},{"key":"2025072618313518600_ezaf200-B23","first-page":"355","article-title":"Mechanical vs bioprosthetic aortic valve replacement in patients younger than 70 years of age: a hazard ratio meta-analysis","volume":"38","author":"Leviner","year":"2022","journal-title":"Can J Cardiol"},{"key":"2025072618313518600_ezaf200-B24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.athoracsur.2020.07.021","article-title":"Subclinical structural valve degeneration in young patients with bioprosthetic aortic valves","volume":"111","author":"Percy","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2025072618313518600_ezaf200-B25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2018.04.064","article-title":"Hemodynamic deterioration of surgically implanted bioprosthetic aortic valves","volume":"72","author":"Salaun","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025072618313518600_ezaf200-B26","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jtcvs.2022.10.023","article-title":"Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position","volume":"167","author":"Francica","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025072618313518600_ezaf200-B27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ejcts\/ezab552","article-title":"Carpentier-Edwards Magna Ease bioprosthesis: a multicentre clinical experience and 12-year durability","volume":"61","author":"Piperata","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025072618313518600_ezaf200-B28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","article-title":"Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants","volume":"99","author":"Johnston","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2025072618313518600_ezaf200-B29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2362.2005.01441.x","article-title":"Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery","volume":"35","author":"Konakci","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"2025072618313518600_ezaf200-B30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41591-022-01682-w","article-title":"The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration","volume":"28","author":"Senage","year":"2022","journal-title":"Nat Med"},{"key":"2025072618313518600_ezaf200-B31","doi-asserted-by":"crossref","first-page":"ezac115","DOI":"10.1093\/ejcts\/ezac115","article-title":"Immunoreaction to xenogenic tissue in cardiac surgery: alpha-Gal and beyond","volume":"62","author":"Calafiore","year":"2022","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezaf200\/63508107\/ezaf200.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/67\/7\/ezaf200\/63508107\/ezaf200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/67\/7\/ezaf200\/63508107\/ezaf200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T22:31:46Z","timestamp":1753569106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezaf200\/8165431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezaf200","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,17]]},"article-number":"ezaf200"}}